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Abstract We have cloned and characterised the expression of a
new opsin gene, neuropsin (Opn5), in mice and humans. Neuro-
psin comprises seven exons on mouse chromosome 17. Its de-
duced protein sequence suggests a polypeptide of 377 amino
acids in mice (354 in humans), with many structural features
common to all opsins, including a lysine in the seventh trans-
membrane domain required to form a Schi¡ base link with
retinaldehyde. Neuropsin shares 25^30% amino acid identity
with all known opsins, making it the founding member of a
new opsin family. It is expressed in the eye, brain, testis and
spinal cord.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The opsins are a superfamily of membrane bound heptahel-
ical G-protein coupled receptors that can be distinguished on
the basis of their amino acid sequence similarity and by the
presence of a lysine (K) residue located in the seventh trans-
membrane domain [1]. During the course of vertebrate evolu-
tion gene duplications have led to the formation of distinct
opsin families. Within these families, members exhibit s 75%
amino acid identity, even from distantly related species such
as human and gold¢sh, whilst opsins from di¡erent families
show 25^40% identity to one another [2].
Despite the diversity of opsin families, all those members
for which a biochemical function has been described use the
conserved lysine residue in the seventh transmembrane do-
main to bind a retinaldehyde chromophore via a Schi¡ base
linkage. The photosensitivity of retinaldehyde is critical to
their function. Members of the vertebrate ancient (VA)-opsin
[3], pinopsin [4], as well as the rod and cone opsin families [1]
employ the 11-cis isoform of retinaldehyde to function as
sensory photopigments. Absorption of light by the 11-cis
chromophore causes an isomerisation to the all-trans confor-
mation, which induces conformational changes in the opsin
protein, allowing activation of a G-protein phototransduction
cascade [5]. The other opsin families with a clearly de¢ned
function (peropsin and RGR-opsin) have a di¡erent, but re-
lated role as photoisomerases. They bind all-trans retinalde-
hyde and use light energy to regenerate the 11-cis isoform
[6^9].
The mammalian genome lacks several of the opsin families
retaining only members of the rod opsin, some cone opsin,
melanopsin, encephalopsin/panopsin, RGR-opsin and perop-
sin families. Two of these, melanopsin and encephalopsin,
have unknown function. The inner retina of mammals con-
tains recently discovered non-rod non-cone photoreceptors,
which employ a retinaldehyde-based photopigment, whose
identity remains unknown [10^13]. Currently, melanopsin
and encephalopsin are the only opsins known to be present
in the mammalian inner retina [14]. The best candidate for the
protein moiety of the unidenti¢ed photopigment is melanop-
sin, which is expressed in these inner retinal photoreceptors
[13]. Ablation of the melanopsin gene renders them insensitive
to light [15]. Thus, melanopsin is a critical component of inner
retinal photoreceptors. However, whether it functions as a
photopigment and/or a photoisomerase remains unclear [16].
Inner retinal photoreceptors are distant from the retinal pig-
mented epithelium (RPE), the principle site of chromophore
regeneration, and may require their own local isomerase. It
may be that multiple opsin proteins are involved in the oper-
ation and maintenance of these novel photoreceptors.
An interesting feature of encephalopsin is its expression in
cells or tissues classically considered to be non-photosensitive,
such as lung, liver and kidney [17]. In teleosts a di¡erent opsin
family (TMT-opsin) shows a similarly widespread expression
pattern [18]. An expansion in assays for photoresponsiveness
has revealed light sensitivity in many peripheral organs in ¢sh
[19], suggesting a role for TMT-opsins in photodetection. By
contrast, the eyes and skin remain the only mammalian tissues
known to be directly photosensitive. Whether the extraocular
expression of mammalian encephalopsin re£ects currently un-
discovered photosensitivity in these tissues or a role for this
opsin in non-photosensory pathways remains unknown.
In this paper we describe a bioinformatic and molecular
approach for the identi¢cation of new members of the opsin
superfamily in the mammalian genome. We report the isola-
tion of a novel mammalian opsin-like gene, Opn5, the ¢rst
member of a new opsin family. We have determined its gene
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structure, chromosomal localisation and tissue expression pat-
tern in mice and humans. The expression of Opn5 in the eye
(retina and RPE) and brain suggests that it will provide new
opportunities to examine the possible roles of mammalian
opsins in inner retinal photoreception and/or non-light-depen-
dent pathways.
2. Materials and methods
2.1. Database searches
A bioinformatic screen for novel opsins was undertaken using the
TBLASTN programme (http://www.ncbi.nlm.nih.gov/BLAST) [20],
using the protein coding sequences of known opsins (rhodopsin,
XM_003284; pinopsin, AAA64223; peropsin, AAC51757; RGR-op-
sin, AAA56748; and melanopsin, NP_150598) as query sequences to
look for signi¢cant matches, including a match to the critical lysine
residue (equivalent to K296 of rhodopsin). Default parameters were
used with the descriptions and alignments options set at 250. The
BLAST suite of programmes at NCBI (http://www.ncbi.nlm.nih.
gov/BLAST) was also used for subsequent screening and sequence
data analysis.
2.2. RNA isolation and tissue expression
Total RNA was isolated from a panel of nine mouse tissues, human
retina and brain, and the human Y79 and ARPE19 cell lines [21,22]
using TRI reagent (Sigma) according to the manufacturer’s instruc-
tions. Single-stranded cDNA was synthesised using the SuperScript
First-Strand Synthesis System for reverse transcription-polymerase
chain reaction (RT-PCR) (Invitrogen). Primers were designed to am-
plify a 218 bp fragment (NOPF: 5P-AGC CTT TGG AAG GCC
AGA C-3P and NOPR: 5P-CAG CAC AGC AGA AGA CTT C-3P)
in order to analyse the tissue expression pattern of the novel opsin.
This product spanned an intron to avoid contamination from genomic
DNA. Hprt (hypoxanthine phosphoribosyltransferase) was used as a
control to demonstrate mRNA reverse transcription ¢delity in all
samples. The Hprt primers encompassed two introns and were de-
signed to amplify a fragment of 334 bp: 5P-GAT GAA CCA GGT
TAT GAC C-3P and 5P-TTG AGA GAT CAT CTC CAC C-3P. PCRs
were performed in a total volume of 25 Wl with 12.5 pmol of each
primer, 0.5 nmol each of deoxyadenosine triphosphate (dATP), deox-
ycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP)
and deoxythymidine triphosphate (dTTP), and 0.25 units of BioTaq
polymerase (Bioline) in the manufacturer’s NH4 bu¡er at an anneal-
ing temperature of 55‡C and at 1.5 mM MgCl2.
2.3. 3P end sequence
The 3P end of the murine Opn5 cDNA was obtained using the
following gene speci¢c primers in conjunction with the 3P RACE
System (Life Technologies) ^ NOPF and NOP2F: 5P-GAA GTC
TTC TGC TGT GCT G-3P. The 3P end of the human Opn5 cDNA
was obtained by a combination of sequencing and RT-PCR. IMAGE
[23] clone 4824978 was obtained from the MRC Geneservice (Babra-
ham, UK). This testis-derived clone was sequenced and found to
contain the 3P untranslated region (UTR) sequence of human Opn5.
RT-PCR using the primers HNO3F: 5P-GCT GCA CAC CGT AAC
CAC-3P and HNO3R: 5P-CAG TTT CTG CCT ACA TGG-3P con-
¢rmed the presence of this sequence in the human retina and brain
Opn5 transcripts.
2.4. In silico analysis to obtain the 5P end sequence
An in silico approach was undertaken to identify the 5P end se-
quence of the Opn5 cDNA as conventional 5P RACE proved unsuc-
cessful. The partial murine Opn5 sequence was used to screen the
genomes/fugu_gs database using the BLASTX programme. A signi¢-
cant match to a predicted fugu protein was identi¢ed, and this protein
was subsequently used to re-screen the databases with the TBLASTN
programme. This enabled the identi¢cation of the orthologous regions
of coding sequence within the mouse and human genomes. From this
new sequence, primers were designed for use in RT-PCRs, to con¢rm
the presence of the 5P exons as part of the full-length mouse and
human Opn5 transcripts. The primers used were: RN1F: 5P-ACA
GCA TGG CCT TGA ACC-3P, RN2F: 5P-ATT CAC GGA CTT
GTT ATT CC-3P, HUMF1: 5P-ACA GAA TGG CGT TAA ATC
AC-3P, NOPR and MNO6R: 5P-CTT ATT TCT GAA GCC CTG-3P.
2.5. Cloning and sequencing
All PCR products were ligated into pGEM-T-Easy vector (Prom-
ega) and transformed in DH5K subcloning e⁄ciency competent cells
(Invitrogen). Nucleotide sequence determination was carried out on
an ABI Prism 377 DNA Sequencer (Perkin Elmer) using the ABI
Prism BigDye terminator cycle sequencing kit (Perkin Elmer). To
eliminate the possibility of PCR generated sequence errors the cloned
products from three independent PCR ampli¢cations were sequenced
on both DNA strands.
2.6. Phylogenetic analysis
Nucleotide coding sequences were entered in to DAMBE version
4.1.15 [24] (http://aix1.uottawa.ca/Vxxia/software/software.htm), and
converted to amino acid sequences which were then aligned using the
Clustal W [25] option. Maximum likelihood analysis was performed
by quartet analysis using TREE-PUZZLE 5.0 [26] (http://www. tree-
puzzle.de/). Reliability values are based on quartet puzzling with
10 000 puzzling steps, VT model and assuming uniform rate hetero-
geneity.
3. Results and discussion
3.1. Identi¢cation and isolation of the Opn5 gene in mouse and
human
A bioinformatics approach was used to identify novel op-
sin-like sequences in the mammalian genomes that are avail-
able on the public databases. The GenBank database was
screened with representative members of the various opsin
classes using the TBLASTN algorithm. Only those unique
results showing a match to the lysine residue that forms the
retinal attachment site of the opsin query sequence were se-
lected for further analysis. The only novel match obtained was
for an expressed sequence tag (EST) (AI810121) correspond-
ing to the 3P end of IMAGE clone 2360502 which is derived
from a pooled human library comprising foetal lung, B-cell
and testis tissue. A second human EST (BG721121) corre-
sponding to the 5P end of IMAGE clone 4824978 that is
derived from a human testis library was also identi¢ed in
all of the database searches. The EST AI810121 sequence
was subsequently used to search the databases through the
TBLASTN programme. A signi¢cant match was identi¢ed
to EST BB633508, corresponding to the 5P end of a RIKEN
mouse clone [27] from an adult spinal cord library. The avail-
able nucleotide sequence from these ESTs was used to design
primers for further analysis.
Both RT-PCR and RACE PCR were carried out in order
to isolate a partial cDNA sequence from mouse eye and brain.
An in silico approach was then undertaken to complete the
full-length coding sequences. The partial murine sequence
identi¢ed a signi¢cant match of 71% identity to the predicted
Fugu protein FuguGenscan_19252, comprising 359 amino
acids. This protein sequence was subsequently used to re-
screen the databases to identify the orthologous upstream
sequences within the mouse genome. The putative 5P exons
were then con¢rmed by RT-PCR on mouse eye and brain
cDNAs. This combination of approaches enabled the identi-
¢cation of a novel mouse cDNA sequence of 1825 bp (Gen-
Bank accession number: AY318865). This sequence contains
an open reading frame of 1134 bp that encodes for a protein
of 377 amino acids. BLAST analysis of the protein sequences
con¢rmed that it is a member of the opsin superfamily, and
no matches were observed to any other class of G-protein
coupled receptors. The predicted amino acid sequence shows
around 25^30% identity to other vertebrate and invertebrate
members of the opsin superfamily, as shown in Table 1, de¢n-
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ing it as a novel opsin family. For this reason we have des-
ignated the gene Opn5 (opsin5). The putative mouse Opn5
sequence was analysed using the online TMHMM Server ver-
sion 2.0 [28,29] (http://www.cbs.dtu.dk/services/TMHMM/)
which predicted seven transmembrane domains as would be
expected of an opsin protein (data not shown).
Subsequently, RT-PCR and sequence data from IMAGE
clone 4824978 were used to identify the human Opn5 gene.
The human sequence comprises 1778 bp (GenBank accession
number: AY377391) and contains an open reading frame of
1065 bp that encodes for a protein of 354 amino acids. Hu-
man and mouse Opn5 show high levels of identity to one
another (Fig. 1A); 89% at the nucleotide level and 95% at
the protein level, which suggests strict functional constraints.
The most signi¢cant di¡erence between the mouse and human
sequences is at the C-terminal tail of the protein, where there
Table 1
Amino acid identity (%) of the transmembrane domains (equivalent to amino acids 35^306 of the rod opsin model of Palczewski et al. [48])
shared by representatives of various opsin families
RHO P VA OPN3 RGR RRH OPN4 Opn5 Sepia
Human rod (RHO) 3/3
Chicken pinopsin (P) 48 3/3
Carp VA-opsin (VA) 37 45 3/3
Human encephalopsin (OPN3) 31 30 29 3/3
Human RGR-opsin (RGR) 23 23 21 25 3/3
Human peropsin (RRH) 27 26 27 30 26 3/3
Human melanopsin (OPN4) 27 28 27 28 26 30 3/3
Mouse neuropsin (Opn5) 25 26 25 27 25 29 28 3/3
Sepia rhodopsin (invertebrate) 27 26 23 25 22 27 41 30 3/3
Fig. 1. A: Alignment of mouse and human Opn5 protein sequences. Dots indicate amino acid identity, which is 95% between the two species.
B: Schematic diagram of the relative positions of introns of the opsin gene superfamily in mammalian genomes (numbered vertical bars). Con-
served intron positions are indicated by dashed vertical lines. In the Opn5 gene, the position of intron 1 is conserved with the corresponding in-
tron in the peropsin gene, RRH, and the RGR-opsin gene, RGR. Intron 3 of Opn5 is also conserved with intron 3 of RRH, whilst intron 4 of
Opn5 is at a position conserved with intron 5 of RRH. This conservation of intron positions may be indicative of a common ancestry [41].
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are an additional 23 amino acids in mouse Opn5. The func-
tional signi¢cance of the longer protein remains to be deter-
mined, but species di¡erences in the length of the C-terminal
tail of opsin proteins have been previously documented [30].
Alignment of the Opn5 proteins with representatives of
other opsin classes reveals that several key features are con-
served (see Fig. 2). These include the lysine residue at position
296 required to form the Schi¡ base with the chromophore,
equivalent to K296 in rhodopsin. The positively charged
Schi¡ base is balanced by a counterion in the third transmem-
brane domain, which is an acidic residue (glutamate) in most
vertebrate visual opsins [2]. The putative counterion in the
Opn5 protein is a tyrosine residue at position 109. Tyrosine
has also been identi¢ed as the possible counterion in peropsin
[31], melanopsin [32] and TMT-opsin [18], and is found in
invertebrate visual pigments at this position [33]. Another
characteristic feature of opsin proteins is a C-terminal tail
enriched for serine and threonine residues as these are sites
for phosphorylation by various kinases [34]. The C-terminal
tail of both mouse and human Opn5 shows enrichment of
these amino acids, and a scan of the sequence using the PRO-
SITE programme [35] (http://us.expasy.org/cgi-bin/scanpro-
site) identi¢ed ¢ve such phosphorylation motifs. Additionally
Opn5 contains an N-linked glycosylation site (residues 4^7), a
site at the C-terminus for palmitoylation (C315, C316), two
cysteine residues for disulphide bond formation (C106 and
C183), and a conserved amino acid tripeptide aspartate, argi-
nine and tyrosine (DRY 130^132) at the end of transmem-
Fig. 2. Alignment of the predicted amino acid sequence of neuropsin with representatives of other opsin groups indicates that several features
of neuropsin are conserved such as the probable lysine retinal attachment site (K296) in the seventh transmembrane domain, and the potential
tyrosine counterion (equivalent of E113) in the third transmembrane domain (numeration and helices based upon the rhodopsin model of Pal-
czewski et al. [48]). Key features of neuropsin mentioned in the text are shown in bold or underlined.
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brane domain 3, which is important for G-protein binding
[36,37]. These features are found in many opsin classes, but
are not diagnostic for the opsin family as they are also found
in other G-protein coupled receptors [38].
The length of the second extracellular loop has been found
to vary between opsins [4]. In rod and cone opsins this loop is
two amino acids longer than in all other vertebrate and in-
vertebrate opsins. Interestingly, like the rod and cone opsins,
Opn5 has the extra two amino acids in the second extracellu-
lar loop between the fourth and ¢fth transmembrane domains
(Fig. 2: alanine, serine AS 192^193). The second extracellular
loop has been suggested to play a role in both the correct
folding of the membrane embedded helices and in stabilisation
of the physiologically active meta II intermediate form of the
opsin molecule [39]. Site-directed mutagenesis studies have
been carried out on this region of pinopsin, which has been
shown to form a functional photopigment, but lacks the extra
amino acid doublet [40]. Swapping a six amino acid stretch
from extracellular loop 2 of chicken pinopsin for an equiva-
lent eight amino acid stretch from this region of chicken green
cone opsin resulted in a more rapid decay of the meta II
intermediate of the mutant pinopsin. As the individual amino
acid residues from this region are not conserved between dif-
ferent rod and cone pigments it is thought that the length of
the loop sequence may be the factor important for determin-
ing the stability [40]. If Opn5 does form a photopigment then
the presence of the extra doublet in extracellular loop 2 sug-
gests that the turnover of the meta II Opn5 intermediate may
be rapid.
3.2. Gene structure and chromosomal localisation of Opn5
A comparison of the mouse and human Opn5 cDNA se-
quences with the genomic sequence available on the public
database reveals that the gene comprises seven exons, with
six introns present in the coding sequence (GenBank:
BK001605). All introns are £anked by consensus acceptor
and donor splice sites. Employing the model of Bellingham
et al. [41], an alignment of the Opn5 coding sequences with
those of representatives from other opsin families indicates
that the insertion site of intron 1 is conserved with the posi-
tion of intron 1 in RGR (RGR-opsin) and RRH (peropsin).
Introns 3 of Opn5 and RRH are also in homologous positions,
as are Opn5 intron 4 and RRH intron 5. The positions of
introns 2, 5 and 6 in the Opn5 gene are unique amongst the
known vertebrate opsin genes, con¢rming that Opn5 repre-
sents a novel opsin family (Fig. 1B).
In both mouse and human eye and brain a splice variant
was detected that contained an extra exon between exons 3
and 4. However, this exon contains two in-frame stop codons,
which would result in production of a truncated protein.
Whether this alternative transcript has a functional role re-
mains undetermined.
In order to localise the Opn5 gene, the cDNA sequence was
used as a search tool in a BLAST analysis of the murine
genome. Opn5 was found to map to mouse chromosome 17,
to a region at approximately 40.8 Mb, corresponding to cy-
togenetic interval 17B3. This places Opn5 between the known
genes Rhag (rhesus blood group-associated A glycoprotein) at
39 Mb and Cd2ap (CD2-associated protein) at 41 Mb. Human
Opn5 maps to the orthologous region on the short arm of
chromosome 6, to a region at approximately 47 Mb, corre-
sponding to cytogenetic interval 6p21^p12.
Recently, a modi¢er locus was identi¢ed on mouse chromo-
some 17 that modulates acute light suppression of activity in
melanopsin knockout animals depending on their genetic
background [42]. Genotyping of the strains involved showed
that the modi¢er gene is located in a 6 Mb region at approx-
imately 19^25 Mb of mouse chromosome 17. This localisation
excludes the Opn5 gene from being the modi¢er for masking
activity.
3.3. Tissue expression of Opn5 (neuropsin)
The expression pattern of the Opn5 gene was analysed in a
panel of nine mouse tissues. RT-PCR showed expression is
detectable in the eye, brain and testis (Fig. 3A and B). Sim-
ilarly, in humans, expression of Opn5 was detected in the
retina, brain and cell lines derived from neural retina (Y79)
and the RPE (ARPE19) (Fig. 3C). Human Opn5 is also ex-
pressed in the testis as ESTs AI810121 and BG721121 are
both derived from testis cDNA libraries. The relevance of
the testis expression is unclear. The ¢nding that genes that
are normally tissue speci¢c can also be ectopically expressed
in the testis has been previously documented. Retinal S-anti-
gen (arrestin) for example, has been shown to be expressed in
the testis [43], and we have observed expression of rod opsin,
the rod cell photopigment in murine testis (data not shown).
Whether Opn5 protein has a function in the testis or whether
there is merely ectopic Opn5 mRNA expression in the testis
remains to be determined. Apart from the testis expression,
Opn5 expression appears to be neural speci¢c, with known
sites of expression in the eye, brain and spinal cord (EST
BB633508). For this reason we have termed Opn5 neuropsin
(from neural opsin).
Fig. 3. RT-PCR analysis of the expression of neuropsin in a panel
of mouse and human tissues. A: Neuropsin expression is observed
in the mouse brain, eye and testis. The positive control (+ve) was a
cloned and sequenced Opn5 PCR product. Negative controls (3ve)
had no cDNA. B: Hprt was used as the housekeeping positive con-
trol gene to con¢rm the ¢delity of the reverse transcription reaction.
C: Neuropsin (left side) and HPRT (right side) expression in human
eye and brain. Neuropsin is expressed in the retina, brain and Y79
and ARPE19 cell lines.
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Within the eye, human Opn5 is expressed in both the neural
retina (retinal and Y79 cDNA), and the RPE (ARPE19
cDNA). These sites of expression support the possibility
that neuropsin may perform some function in light detection.
In contrast, expression in the brain would appear to exclude
such a role, as extraocular photoreception is not found in
mammals. One possibility to exclude is that the RT-PCR sig-
nal from brain re£ects Opn5 expression only in the pineal
gland, similar to the rod and cone opsins [44], as a portion
of the neuropsin 3P untranslated sequence identi¢es a mouse
RIKEN EST (GenBank: AV381963), which is derived from
an adult diencephalon library. In non-mammalian species se-
lected areas within the diencephalon, in particular the anterior
medial preoptic area and the paraventricular nuclei have been
reported to be involved in light detection [45]. Although these
brain regions have not been shown to play a role in light
detection in mammals, there is evidence that light can perme-
ate through the skull to areas of the mammalian brain includ-
ing the diencephalon [46]. Encephalopsin (Opn3), another
member of the opsin family, is expressed at high levels in
several regions of the mouse brain, including the diencephalon
[47]. Further characterisation of the sites of expression of
neuropsin within the eye and brain will provide an insight
into the potential role of this novel opsin.
3.4. Phylogenetic position of neuropsin
A maximum likelihood tree of representatives from various
vertebrate opsin families was constructed from amino acid
data (Fig. 4). It can be seen that neuropsin (Opn5) would
appear to be most closely related to peropsin (RRH) in the
RGR-opsin/peropsin clade. Although branch support levels
for and within this clade are relatively low, and the levels of
amino acid identity between Opn5 and RGR-opsin/peropsin
are no higher than the levels of identity observed with the
other opsin families, the phylogenetic relationship between
these opsins is strengthened in part by their shared intron
structure (see Section 3.2).
3.5. Conclusions
We have utilised both bioinformatic and molecular ap-
proaches to identify a new member of the opsin superfamily,
neuropsin (Opn5) in the mammalian genome. Since neuropsin
shows 25^30% identity to the known opsins, we have desig-
nated it the ¢rst member of a new opsin family. It retains all
of the amino acid residues critical for opsin function including
a putative lysine retinaldehyde chromophore binding site in
the seventh transmembrane domain. Neuropsin expression in
mouse is con¢ned to the eye, brain, spinal cord and testes.
Human neuropsin expression has been detected in brain and
testis and has been sub-localised within the eye to the neural
retina and RPE. Further sub-localisation of neuropsin expres-
sion within neural tissues, in conjunction with functional stud-
ies of the protein will provide more insight into its role. Our
strategy of using both comparative bioinformatics and con-
ventional molecular techniques was critical in identifying the
full-length coding sequence for Opn5, and it is likely that
similar approaches will be of use for the identi¢cation of
rare transcripts in general. To date, our search strategy has
failed to identify any further opsin-like genes in the mamma-
lian genome. This suggests that if further opsin genes exist in
mammals, they are currently not represented by ESTs and are
in regions of the genome poorly represented on the databases.
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